Abstract. Neurokinin-1 receptor immunoreactive (NK1R-ir) neurons and processes are widely distributed within the medulla, prominently at central chemoreceptor sites. Focal lesions of NK1R-ir neurons in the medullary raphe or the retrotrapezoid nucleus partially reduced the CO 2 response in conscious rats. We ask if NK1R-ir cells and processes over a wide region of the ventral medulla are essential for central and peripheral chemoreception by cisterna magna injection of SSP-SAP, a high-affinity version of substance P-saporin. After 22 days, NK1R-ir cell loss was -79 % in the retrotrapezoid nucleus and -65 % in the A5 region, which lie close to the ventral surface, and -38 % in the medullary raphe and -49% in the pre-Bötzinger complex/rostral ventral respiratory group, which lie deeper. Dorsal chemoreceptor sites, the caudal nucleus tractus solitarius and the A6 region, were unaffected. At 8 and 22 days, these lesions produced a) hypoventilation during air breathing in wakefulness (~8%) and in NREM (~9%) and REM (~14%) sleep as measured over a 4-hour period, b) a substantially reduced ventilatory response to 7% CO 2 by 61% in wakefulness and 46-57% in NREM sleep, and c) a decreased ventilatory response to 12% O 2 by 40 % in wakefulness and 35% in NREM sleep at 8 days with partial recovery by 22 days. NK1R-ir neurons in the ventral medulla are essential for normal central chemoreception, provide a drive to breathe and modulate the peripheral chemoreceptor responses. These effects are not state dependent.
Introduction
NK1R-ir neurons and processes are widespread within the brainstem (5, 18, 30, 37, 54) .
Locations that are rich in NK1R-ir include all known brainstem chemoreceptor sites and the preBötzinger complex (PBC) (14, 17) a site that is important in the generation of a normal respiratory-like rhythm in reduced preparations (see 12) and in normal awake (14) and sleeping rats (27) and goats (55) .
The natural ligand for the NK1R, substance P, is a peptide neuromodulator with known involvement in the control of breathing. In reduced preparations, substance P has strong stimulatory effects on respiratory system output (44, 45) and on neurons within the PBC (15, 40, 59 ). In anesthetized rats, focal injection of substance P into the nucleus tractus solitarius (NTS) or the ventral medulla stimulates breathing while focal application of a substance P antagonist in the ventral medulla inhibits breathing (6, 7) .
Central chemoreceptor sites that detect increases in CO 2 or H + and stimulate breathing are widely distributed in the brainstem (8, 12, 23, 31, 32, 34, 35, 39) . Ventral sites include the medullary raphe (MR) with involvement of serotonergic neurons (47, 48) , the retrotrapezoid nucleus (RTN) with involvement of glutamatergic neurons (19, 29) , the A5 region with possible involvement of catecholaminergic neurons (22) and PBC/ rostral ventral respiratory group (rVRG) (34) . Dorsal sites include the locus ceruleus (A6) (22, 43) , the caudal NTS (cNTS) (36) , and the fastigial nucleus of the cerebellum (57, 58) . NK1R-ir is strikingly present at all of these central chemoreceptor locations within the brainstem (30, 37) . It is not known whether it is present within the fastigial nucleus of the cerebellum. Focal application of a substance P antagonist in the ventral medulla (6, 7) and focal lesions of NK1R-ir neurons in the PBC (14) , the RTN (37) , and the MR (39) each reduced the ventilatory response to increased CO 2 .
Page 3 of 48 3 Substance P and NK1Rs are also involved in the ventilatory response to hypoxia, which is mediated through the carotid body via the NTS with modulation by the RTN (51) . Genetically modified mice, which do not express NK1Rs, have a reduced ventilatory response to hypoxia as adults (46) as do rats after focal application of a substance P antagonist in the ventral medulla (6, 7) suggesting that NK1R-expressing neurons within the ventral medulla participate in hypoxic chemoreception.
We hypothesize that NK1R-ir neurons and processes within the ventral medulla are essential for central and peripheral chemoreception and contribute to the drive to breathe under normal air breathing conditions. To test this hypothesis we produce a widespread lesion of NK1R-expressing neurons and processes within the ventral medulla by injection into the cisterna magna of SSP-saporin (SAP) (56) , a specific and potent toxin for NK1R-expressing neurons. We produced large lesions of NK1R-ir neurons in the ventral medulla of conscious rats, which reduced ventilation during air breathing and the ventilatory response to 7% CO 2 at 8 and 22 days after the injection and the ventilatory response to 12% oxygen at 8 days with partial recovery at 22 days. The lesions did not affect oxygen consumption, body temperature, the frequency of spontaneous deep breaths, or sleep cycling.
Methods

General
The methods are essentially the same as in a recently published study from our lab (22) except that the injections were of SSP-SAP into the cisterna magna. All procedures followed the guidelines of the National Institutes of Health for animal use and care and were approved by the Dartmouth College Institutional Animal Use and Care Committee. A total of 20 male SpragueDawley rats (250-350g) were used of which 13 completed the entire 4 week protocol. There Page 4 of 48 4 were two groups; SSP-saporin (SAP) injection lesion (n=7); IgG-SAP injection control (n=6).
The rats were anaesthetized with ketamine (100 mg kg -1 I.M.) and xylazine (15 mg kg -1 , I.P.). To monitor the depth of anesthesia, we tested hindlimb withdrawal and corneal reflexes and responses resulted in administration of supplemental anaesthesia in the form of a quarter of the initial dose. The skull and a portion of the abdomen were shaved and the skin cleansed with betadine and alcohol. The head was placed into a Kopf stereotaxic holder and two EEG electrodes were screwed into the right side of the skull. One was over frontal cortex (2 mm anterior to bregma and 2 mm lateral to midline), another over parietal cortex (3.5 mm posterior to bregma, 2 mm lateral) and an earth lead placed between the two 3 mm lateral to midline. For the EMG, a pair of wire electrodes was threaded through the nuchal muscles. Through a separate incision, a sterile telemetry temperature probe (TA-F20, Data Sciences, St Paul, MN, USA) was placed in the abdominal cavity. After at least 7 days recovery and baseline data collection, each rat was re-anesthetized with the same doses of ketamine and xylazine and received a microinjection of either SSP-SAP or IgG-SAP into the cisterna magna. A dorsal incision was made over the neck muscles, which were then retracted to expose the atlanto-occipital membrane. The microinjection was made using a 10 Jl Hamilton syringe with a 28 gauge needle inserted into the cistern through the membrane. The needle remained in position for another 5 min before removal. After each procedure, the wound was sutured.
Protocol
The rats were housed in a room in the Animal Research Facility with a light, rest period from midnight to noon and a dark, active period from noon to midnight. Food and water were available ad libitum. All the experiments were performed between 8 AM and 3 PM. Each rat was studied over a period of 4-6 hrs. After at least 7 days recovery from the EEG/EMG placement, After obtaining these baseline data, each rat then received one injection (250-280 ng in 2.5-2.8 Jl) of one of the following agents, mouse IgG-saporin (IgG-SAP) or SSP-SAP (Advanced Targeting Systems, San Diego, CA, USA). Ventilatory measurements were again made on days 8 and 22 after the injection. Sleep cycling was measured in a subset of rats during 24 hr of air breathing during the pre-injection baseline period and at 10 and 22 days after the injection. All rats also had a second 4 hour period of room air breathing analyzed for ventilation and for periodic deep breaths or sighs. These were defined as a tidal volume that was at least 2 times larger than any of the 5 previous breaths and were counted over a 4 hr period of room air breathing in both NREM sleep and wakefulness. These 4 and 24 hr periods occurred on separate days from the CO 2 and hypoxic tests.
Data analysis
Page 6 of 48 6 We determined the times of sleep and wakefulness using EEG and EMG electrode signals, the fast Fourier transform (FFT) of the EEG signal analysed in 3.6s epochs at delta (0.3-5Hz), theta (6-9Hz), and sigma (10-17Hz) frequency bands, and behavioural observations. We used criteria as previously described (37, 39) . In our case, we measured awake breathing only during quiet wakefulness as in active wakefulness the activity of the rat in the plethysmograph interferes with reliable measurement of breathing. For 24 hr sleep cycling data and for analysis of sleep states in the 40-60 min and the 4 hour periods of air breathing we used Sleep Sign™ sleep analysis software (Kissei Comtec America, Inc.) to determine the amount of time the rat spent in wakefulness, NREM and REM sleep. Ventilation was measured using a flow-through whole body plethysmography as previously described (37, 39) . The volume of the plethysmograph was 7.6 l with a 3.5 l top to protect the head pedestal. The plethysmograph was connected by a high resistance leak to a similarly sized reference chamber. The inflow gas for the plethysmograph chamber was humidified and controlled by a flow meter at a minimum of 1.4 l min -1 to prevent rebreathing of exhaled gas. This flow also helped to keep plethysmograph temperature constant.
The outflow was matched to the inflow via a flow meter connected to a vacuum system.
Approximately 100ml min 
Anatomy
Our goal was to substantially reduce the numbers of NK1R-ir neurons and processes within a widespread area of the ventral medulla, an anatomical site that would require multiple tissue injections in vivo. We used a conjugate of the ribosomal toxin saporin with SSP, a substance P-like peptide that has a higher affinity for the NK1R than endogenous substance P (56). The SSP binds to endogenous NK1 receptors, the conjugate is internalized, the ribosomal toxin is released and the cell is killed (56) . We made our injections into the cisterna magna as the cerebrospinal fluid flows laterally from the cistern down and around the medulla to reach the Chemicon, CA), or a mouse monoclonal antibody against TH (1:10,000, Sigma) for 48h at 4°C
followed by a biotinylated goat anti-rabbit IgG for NK1, or anti-mouse IgG for TH overnight at 4°C (1:500, Vector Laboratories, Burlingame, CA, USA). An avidin-biotin-horseradish peroxidase procedure with diaminobenzidine was used to visualize NK1 and TH staining. These sections were used for all cell counts. All the sections were mounted and dehydrated with graded alcohol (25-100% EtOH), cleared with xylene and cover-slipped.
Cell counting methods
Brainstem sections were cut at 30 Jm thickness in a cryostat with 1 of every 3 successive sections stained for NK1R-ir or TH-ir. To evaluate the effects of our SSP-SAP injections into the cisterna magna on brainstem NK1R-ir neurons we counted them in putative central chemoreceptor regions as follows. For all cell counts we identified the caudal aspect of the facial nucleus and labeled that as -11.6 mm from bregma, an approach used by Guyenet and colleagues (18, 54) . For the RTN we counted all NK1R-ir cell bodies from ~300 Jm rostral to the rostral pole of the facial nucleus to 200 Jm caudal to the caudal pole of the facial nucleus from just lateral to the pyramids to the lateral aspect of the facial nucleus (9, 37). We counted one section out of every three in 6 control and 4 lesioned rats.
For the MR we counted one out of every three sections from ~ 2000 Jm rostral to ~ 2000
Jm caudal to the caudal end of the facial nucleus (39) . We counted all NK1R-ir cell bodies within the midline and parapyramidal regions in 6 control and 4 lesioned rats (39) .
For the cNTS, we counted NK1R-ir neurons beginning at the rostral aspect of the area postrema and caudally for 720 Jm (36). We counted 1 of every 3 sections in 4 control and 5 lesioned rats.
For the PBC/rVRG we counted NK1R-ir neurons as described by Wang et al., (56) and
Guyenet et al., (18) . They used a small rectangle to limit the area counted; we used a similarly sized circle (the area visualized by the 20X objective). We counted every sixth section from -11.7 to -13.3 relative to bregma in 4 control and 5 lesioned rats.
For A6 and A5, the NK1R-ir pattern consisted largely of small dense fibers with few cell bodies. Given that the catecholaminergic neurons in these sites express NK1 receptors we estimated our lesion effect by counting TH-ir neurons as TH marks neurons that synthesize catecholamines, which here express the NK1 receptor. For A5, we again (22) During the exposure to 7% CO2, there was no significant difference in oxygen consumption between IgG-SAP controls and SSP-SAP lesioned rats at baseline, 8 or 22 days nor was there a difference in body temperature between the two groups. Oxygen consumption remained unchanged during the CO 2 test.
During the exposure to 12% O2, there was no significant difference in oxygen consumption between the two groups nor was there a difference during the exposure period.
Body temperature decreased in both groups during the exposure period by 0.3 to 0.6 degrees C 
Cell counts
The lesion effects of our SSP-SAP injections into the cisterna magna were greatest in areas exposed to the CSF overlying the ventral medulla. Figure 1 shows schematically the locations of our regions of interest in respect to NK1R-ir neurons and central chemoreception and the overall % decrease in cell counts produced in each region by the SSP-SAP injections. In the RTN, the number of NK1R-ir neurons counted decreased 79% from 45 +/-12 (N=6) in controls to 10 +/-4 (N=4) (P < 0.001; t-test). In the MR, they decreased 38% from 167 +/-63 (N=6) to 93 +/-21 (N=4) (P = 0.038, ranked sum test). In the PBC/rVRG, they decreased 49%
from 99 +/-7 (N=4) to 50 +/-15 (N=5) (P < 0.001; t-test). There was no significant effect on the number of NK1R-ir neurons in the caudal NTS. For the A5 and A6 regions we estimated the lesion effect by counting TH-ir neurons since these catecholaminergic neurons express NK1
receptors and there are few NK1R-ir cells but many processes. In the dorsal A6 region there was no significant difference. In the ventral A5 region, the number of TH-ir neurons decreased 62% from 85 +/-10 (N=4) to 33 +/-8 (N=4) (P < 0.001; t-test).
The regions with greatest loss of NK1R-ir neurons, the A5 region and the RTN, lie closest to the ventral surface, the site of access to the brainstem of our injections into the cisterna magna. Figure 2 shows the details of the NK1R-ir neuron counts for the RTN (A) and the TH-ir neuron counts for the A5 region (B). For the RTN the number of NK1R-ir neurons is significantly less in the SSP-SAP group compared to controls (P< 0.001 Treatment effect; RM ANOVA). For the A5 region the number of TH-ir neurons is significantly less in the SSP-SAP group compared to controls (P< 0.004; Treatment effect, RM ANOVA). Of the regions with an Figure 3A it appears that the loss of NK1R-ir neurons is most pronounced at more rostral aspects of our cell count distribution in a region in which serotonergic neurons have greater proximity to the ventral surface. Since there was no significant interactive effect in the ANOVA we cannot show this to be statistically significant. Our dorsal regions of interest, the cNTS and the A6 region, had no significant cell loss; the SSP-SAP did not appear to reach these neurons.
Breathing in air
Analysis of four hours of continuous breathing in air with the rats spontaneously cycling through wakefulness and NREM and REM sleep allowed us to detect a significant decrease in ventilation in lesioned as compared to control rats in all three states (Figure 4 ). An analysis of variance with ventilation as a repeated measure and Treatment and State as categorical variables
showed an overall effect of State (P<0.001), a significant repeated measures effect on ventilation (P < 0.001) and a significant interaction of Ventilation and Treatment (P< 0.001). Oxygen consumption was not significantly different in the control vs lesion groups nor was there an effect of time. We conclude that these SSP-SAP lesions resulted in hypoventilation during air breathing, which was ~8% in wakefulness, ~9% in NREM sleep, and ~14% in REM sleep. Our Examining only the awake data as shown on Figure 5 , absolute ventilation breathing 7% These were large effects; a 61% decrease in TVE at 8 and 22 days in wakefulness for example.
The results in NREM sleep were similar, a 46% decrease at 8 days and a 57% decrease at 22 days (data not shown).
Breathing in hypoxia
As in the hypercapnia exzperiments, in the hypoxia experiments we studied absolute ventilation as a repeated measure (RM) over time with State (awake; NREM sleep), Treatment (IgG-SAP, SSP-SAP), and Gas (air, 12% O 2 ) as categorical variables. There was a significant effect of State as a categorical variable (P< 0.001) but there was no significant interaction between State and V E as a repeated measure. In these experiments ventilation was lower in NREM sleep compared to wakefulness but the effects of Treatment or Gas did not vary by state.
There was a significant interaction between V E and Treatment (P < 0.001), Gas (P< 0.01) and Treatment x Gas (P< 0.001). For tidal volume and frequency there was a repeated measures effect and a significant interaction between them and Gas but no significant interaction between them and Gas x Treatment. This precluded any post-hoc analysis of tidal volume and frequency.
Examining only the awake data as shown on Figure 
Sighs
There was no effect of our lesion on the frequency or duration of periodic deep breaths during 4 hrs of room air breathing. The control and treated groups had between 19 and 21 sighs per hr as measured at baseline, 12 or 23 days after the cisterna magna injections.
Sleep
We measured sleep cycling over 24 hrs in two IgG-SAP controls and three SSP-SAP lesioned animals at 10 and 22 days after the injections. All rats spent more time awake in the dark phase than in the light phase, e.g., 54% vs 33 % for IgG-SAP controls and 54% vs 38% for SSP-SAP lesioned at 10 days, and, conversely, less time in NREM sleep, e.g., 40% vs 58% for IgG-SAP controls and 39% vs 54% for SSP-SAP lesioned at 10 days. REM time was the same in both dark and light conditions. There was no effect of our SSP-SAP injection produced lesions on sleep cycling or on the diurnal rhythm. In the 4 hour air exposures there was no treatment effect with the time spent awake being 36-40%, in NREM sleep, 55-59%, and in REM sleep, 2-5%. In the 40-60 minute air breathing period of the CO 2 and hypoxic tests, there was no treatment effect with the time spent awake being 47-55% and that spent in NREM sleep, 45-53%.
Discussion
Protocol
To obtain breathing data during 7% CO 2 and 12% O 2 tests in both wakefulness and NREM sleep required a 30-40 min exposure to each gas. The data were obtained throughout this exposure period and averaged within each state. Any time related effects that might occur within Page 18 of 48 18 this exposure period have been ignored in order to obtain state specific results. The use of a parallel control group allows us to make treatment specific conclusions on these averaged data.
To evaluate the level of ventilation during air breathing we obtained data over a 4 hour period during a separate experimental day. This longer period breathing only air allowed us to detect hypoventilation.
Lesion size and pattern
Our results showed the greatest cell loss of NK1R-ir neurons at the RTN (-79%) and A5 region (-65%), sites close to the ventral medullary surface, with lesser cell loss at the PBC/rVRG (-49%) and MR (-38%), sites located slightly deeper. There was no effect at dorsal sites, i.e., the cNTS and the A6 region. In the MR, we observed greater cell loss more rostrally at the level of the facial nucleus. As one examines sections caudal to the facial nucleus more serotonergic neurons appear to be dorsally located suggesting that even in the MR our SSP-SAP injections were predominantly affecting neurons or processes near to or at the ventral medullary surface.
Resting ventilation
Focal specific lesions of NK1R-ir neurons and processes in the PBC that produced >80% cell loss in rats resulted in hypoventilation and disordered breathing rhythm in wakefulness and sleep (14) . By day 4 after such PBC injections there is a REM sleep specific disordered breathing (27) . Here our lesion size in the PBC/rVRG region was -49%, a value much below the 80% threshold. We did not observe disordered breathing in wakefulness or in NREM or REM sleep.
We speculate that even the REM sleep specific disordered breathing requires a PBC lesion size of >49%. In contrast to these data in the rat, Wenninger et al., (55) observed abnormal breathing rhythms in goats with a 29% decrease in PBC NK1R-ir neurons. The goat appears to be more 19 sensitive to PBC lesions than does the rat. We conclude that the hypoventilation in our study cannot be directly attributed to the moderately sized lesion in the PBC. . This is analogous to the situation following carotid body denervation in which the CO 2 response is reduced by ~40% but the degree of hypoventilation is less (50) . The control system does not tolerate hypoventilation but seems to function well with quite varying CO 2 sensitivities.
The reduced CO 2 response
Our large and widespread lesions of ventral medullary NK1R-ir neurons and processes resulted in a very large decrease in the ventilatory response to CO 2 , a 61% decrease in an awake conscious rat that was sustained for 8 to 22 days and a 46-57% decrease during NREM sleep. We know of no other manipulation of central chemoreception that has produced an inhibitory effect of equivalent magnitude in a conscious animal. We contend that central chemoreception, as observed in the conscious animal, includes the participation of several chemoreceptor sites within the hindbrain (8, 12, 20, 23, 29, 31, 32, (34) (35) (36) 48) . Sites that induce an increase in ventilation when focally acidified by focal delivery of CO 2 include: the RTN, rVRG, cNTS, A6, fastigial nucleus, and the MR. We will focus our discussion on the four chemoreceptor regions that had substantial loss of NK1R-ir neurons in this study, the MR, RTN, A5, and PBC/rVRG.
There is evidence to support the involvement of serotonergic neurons and the MR as one central chemoreceptor site. Serotonergic neurons of the MR are CO 2 sensitive in culture and in slices (47, 48) ; focal CO 2 stimulation within the MR in vivo increases ventilation in conscious rats (35) and goats (20) ; focal inhibition of serotonergic neurons in vivo by reverse microdialysis of the 5HT 1A receptor agonist 8-OH-DPAT into the MR at the level of the facial nucleus decreases the ventilatory response to CO 2 in conscious adult rats (52) and newborn piglets older than 10 days of age (28); and specific lesions of serotonergic neurons in the MR decrease the ventilatory response to CO 2 in adult rats (39) . However the role of serotonergic neurons in 21 chemoreception may vary by anatomical site, age and gender. In adult rats, dialysis of 8-OH-DPAT into the MR at sites ~ 1 mm caudal to the facial nucleus do not decrease the CO 2 response (24) and up to 65% loss of serotonergic neurons in newborn piglets has no effect on the CO 2 response except in males during NREM sleep (41) . And reverse microdialysis of muscimol, an agonist of GABA A receptors, into the rostral aspect of the MR (the region which had loss of NK1R-ir neurons in this study) actually increases the ventilatory response to CO 2 (53) . We do not know if RTN glutamatergic neurons express NK1-receptors. However, substance P is present in the RTN (25) and RTN neurons that express c-fos when activated by CO 2 contain preprotachykinin mRNA indicating that they contain substance P or neurokinin A (42) . Given the evidence that it is the glutamatergic neurons in the RTN that respond to CO 2 it seems reasonable to presume that they also contain substance P. The pattern of NK1R-ir in the RTN shows a rich network of neuronal processes but few neurons (30, 37) . In this study the widespread lesions of NK1R-ir neurons includes these processes as well as the NK1R-ir neurons within the RTN and the overall effect of our lesions includes the attenuation of the RTN contribution to central chemoreception. Focal unilateral injection of SP-SAP into the RTN produced a 44 % loss of NK1R-ir and a 30% reduction in the CO 2 response in wakefulness (36) .
Following cisterna magna injections of SSP-SAP there was a 79 % loss of NK1R-ir neurons bilaterally and a 61% reduction in the CO 2 response. This comparison of lesion size and physiological effects suggests that the RTN lesions of NK1R-ir neurons/processes could have made a major contribution to the overall 61% reduction in the CO 2 response in this study. We substantially affected yet the CO 2 response was reduced by only 28 %.
The effects of our SSP-SAP injections on NK1R-ir neuron numbers in the PBC and the rVRG could have influenced the CO 2 response. In rats, Gray et al. (14) produced extensive SP-SAP lesions of NK1R-ir neurons within the PBC. Both an abnormal breathing rhythm and a reduced CO 2 response were observed with greater than 80% loss of NK1R-ir neurons. Our PBC lesions were well below this value. We conclude that our 49% loss of PBC NK1R-ir neurons is not the sole cause of the 61% decrease in the CO 2 response. PBC neurons could themselves be chemosensitive and are likely the destination of chemoreceptor derived information via the suggested substance P neurotransmission from MR and RTN. The smaller PBC lesion could contribute to the decreased CO 2 response. In respect to the rVRG, focal reverse microdialysis of a hypercapnic solution does increase ventilation indicating the presence of chemoreception at that site (34) . As in the PBC, neurons in the rVRG could themselves detect CO 2 or they could be influenced by substance P inputs from MR and RTN. In either case, the loss of NK1R-ir neurons there could contribute to the observed 61% decrease in the CO 2 response.
Page 24 of 48 24 The remaining response to CO 2 after the cisterna magna SSP-SAP lesions can be explained by the participation of other chemoreceptors at the carotid body, the A6 region, the cNTS, and the fastigial nucleus of the cerebellum. Recent work has helped to describe the relative importance of central and peripheral chemoreceptors in the CO 2 response. Studies in conscious dogs with denervation of the carotid body on one side and control of the milieu of the carotid body on the other side by perfusion (50) maintain the tonic input from the carotid bodies to the medullary respiratory neurons-something missing in denervation experiments. This work shows that the peripheral chemoreceptor contributes ~40% of the overall response. In studies of conscious rats after acute carotid denervation, the ventilatory response to CO 2 is reduced by 30-40 % (16, 26, 49) . Thus much of the remaining response present after our SSP-SAP induced NK1R-ir cell loss could be attributable to input from the carotid bodies. However, our SSP-SAP lesioned rats also demonstrate a reduced ventilatory response to hypoxia that is present at 8 days after the injection. This indicates that the processing of the CO 2 related afferent excitatory input from the carotid body may also be affected by the NK1R-ir neuronal loss. Insofar as the RTN (38, 51) and the MR (53) may modulate the effects of afferent input from the carotid bodies, we conclude that the remaining CO 2 response in our SSP-SAP lesioned rats is likely due mainly to stimulation at other central chemoreceptor sites and to some amount of carotid body input.
The hypoxic response
We observed a decrease in the hypoxic response observed at 8 days following the SSP-SAP agreeing with observations in the adult NK1R knock-out mouse (46) , which showed a reduced hypoxic response. In that our substantial lesions of NK1R-ir neurons are limited to the ventral medulla, NK1R-ir neurons in these lesion sites must participate in the reduced hypoxic ventilatory response. NTS neurons, which contain preprotachykinin mRNA for substance P/ (11) and muscimol inhibition of the MR produces complex temperature dependent effects on the hypoxic response in conscious adult rats (53) .
The recovery of the hypoxic response by 22 days was surprising in that the CO 2 response showed no such recovery. Rats do show rapid recovery of the hypoxic response following carotid body denervation (49) . In our case, the carotid bodies were intact and the loss of the hypoxic response was due to loss of modulation by, or participation from, ventral medullary neurons/processes lesioned by the SSP-SAP. The partial recovery of the hypoxic response likely reflects plasticity within the medulla involving the ventral medulla and/or the NTS. In this study this plasticity is greater for the hypoxic than for the hypercapnic response.
Significance
We propose that SP is released from glutamatergic chemosensitive neurons of the RTN and from serotonergic chemosensitive neurons of the MR in response to CO 2 stimulation. The MR serotonergic and RTN glutamatergic neurons could be stimulated by CO 2 either directly or indirectly, e.g., by ATP release from near-by surface cells (?glia) (13) or via carotid body afferents through the NTS (51). In either case, the subsequent release of substance P stimulates NK1Rs, which are part of, or are connected to, the respiratory rhythm and pattern generators. We also propose that neurons in the MR and RTN (possibly the same CO 2 sensitive neurons) are activated in hypoxia and release substance P to modulate the hypoxic response (11, 38, 51) . This substance P system contributes to the chemical drive to breathe present under resting conditions as shown by the hypoventilation following the lesions.
Of interest is the human disease multiple system atrophy in which there is severe loss of NK1R-ir neurons in the ventral medulla (3). These patients have disordered breathing and an abnormal ventilatory response to hypoxia (3). Their response to hypercapnia has not been reported.
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